Cargando…

Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia

One of the oldest and most common therapies for endometrial complex atypical hyperplasia (CAH) and low-stage, low-grade endometrioid endometrial carcinoma (EEC) is the use of progestins. Importantly, the use of progestins remains the only fertility-sparing treatment available. Despite frequent initi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gertz, Jay, Rush, Craig, Vahrenkamp, Jeffery, Szczotka, Kathryn, Dodson, Mark, Jarboe, Elke, Soisson, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265772/ http://dx.doi.org/10.1210/jendso/bvab048.2008

Ejemplares similares

FFPEcap-seq: a method for sequencing capped RNAs in formalin-fixed paraffin-embedded samples
por: Vahrenkamp, Jeffery M., et al.
Publicado: (2019)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
por: Shao, Fengping, et al.
Publicado: (2023)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
por: Nwanodi, Oroma
Publicado: (2017)

SUN-901 A Case of Coexisting Insulinoma and Islet Cell Hyperplasia
por: Chin, Yun Ann, et al.
Publicado: (2020)

Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer
por: Blanchard, Zannel, et al.
Publicado: (2019)

MON-310 Oncogenic Roles of Tripartite Motif 25 in Endometrial Cancer
por: Horie-Inoue, Kuniko, et al.
Publicado: (2019)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
por: Miki, Yasuhiro, et al.
Publicado: (2022)

Assessment of Steroid Hormones in Both Saliva and Blood During a Phase 2 Clinical Trial for the Use of Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia
por: Keevil, Brian, et al.
Publicado: (2021)

MON-309 Intratumoral Proliferation and Proinflammatory Macrophages in Obese and Non-Obese Patients with Different Molecular-Biological Types of Endometrial Cancer
por: Berstein, Lev, et al.
Publicado: (2019)

SUN-119 Identification of Novel Mirnas Found to Be Differentially Expressed Between ATA Risk Stratification Groups in Papillary Thyroid Carcinoma
por: A, Luisa Fernanda Olaya, et al.
Publicado: (2020)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

SUN-133 Intratumoral Expression of Steroid Receptors, CD68+ Macrophages and Mdm2 in Different Molecular-Biological Types of Endometrial Cancer
por: Berstein, Lev M, et al.
Publicado: (2020)

Markers of Lymphocytic-Macrophagal Infiltration and Their Association With the Receptor Phenotype and Proliferative Activity of Tumor Tissue in Various Molecular-Biological Types of Endometrial Cancer
por: Berstein, Lev M, et al.
Publicado: (2021)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
por: Baek, Ji Sun, et al.
Publicado: (2016)

DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma
por: Zhou, Qing, et al.
Publicado: (2019)

An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations
por: Yang, Chieh-Hsiang, et al.
Publicado: (2015)

Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line
por: Rush, Craig M., et al.
Publicado: (2022)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
por: Kim, Mi Kyoung, et al.
Publicado: (2020)

OR27-06 Identification And Functional Analyses Of Therapeutic Targets For Testicular Germ Cell Tumors
por: Horie, Kuniko, et al.
Publicado: (2023)

MON-339 Differential Non-Endocrinological Diagnoses of Retroperitoneal Injury: Report of 2 Cases
por: Naldi, Murilo, et al.
Publicado: (2019)

Well-Differentiated Malignant Neuroendocrine Cell Tumor Originating From the Jejunum With Excessive Insulin Secretion
por: Ahmed, Haris, et al.
Publicado: (2021)

Stress-Induced Differential miR-4633-5p Expression in Thyroid Cancer Health Disparities
por: Mancao, Jonathan, et al.
Publicado: (2021)

THU514 Atypical Presentation Of Birt-Hogg-Dubé Syndrome With Poorly Differentiated Follicular Thyroid Cancer And Paraganglioma
por: Lertdetkajorn, Khemaporn, et al.
Publicado: (2023)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
por: Hu, Yang, et al.
Publicado: (2021)

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
por: Zhou, Shuang, et al.
Publicado: (2021)

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis
por: Zhang, Yu-Fei, et al.
Publicado: (2023)

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
por: Yang, Linlin, et al.
Publicado: (2020)

PSAT275 A Rare Case of Thyroid-Stimulating Immunoglobulin-Induced Thyrotoxicosis in Poorly Differentiated Metastatic Thyroid Cancer
por: Berardo, Jeronimo, et al.
Publicado: (2022)

RF07 | PSUN359 Alpelisib-induced Diabetic Ketoacidosis
por: Majumdar, Sachin, et al.
Publicado: (2022)

THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)

THU527 Metastatic Adenocarcinoma Of The Colon Concealing An ACTH Secreting Neuroendocrine Differentiated Cluster: A Lethal Zebra Within A Trojan Horse
por: Velasquez, Mariana, et al.
Publicado: (2023)

SUN-329 177Lu-DOTA-TATE Treatment in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors: A Single-Center 7-Year Experience
por: Gouveia, Pedro, et al.
Publicado: (2019)

Taking Advantage of the TGFB1 Biology in Differentiated Thyroid Cancer to Stimulate Sodium Iodide Symporter (NIS)-Mediated Iodide Uptake in Engineered Mesenchymal Stem Cells
por: Han, Yang, et al.
Publicado: (2021)

ODP558 Steroid Receptor Coactivators Promote Non-Small Cell Lung Cancer Tumorigenesis by Inhibiting Differentiation Factors, C/EBPα and NF-κB
por: Mendelson, Carole, et al.
Publicado: (2022)

Response to comment on: Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gjurh1jqtk8qeqbilhg4o600u4